Banque Cantonale Vaudoise Has $4.95 Million Stake in HCA Healthcare, Inc. (NYSE:HCA)

Banque Cantonale Vaudoise increased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 25.6% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 12,187 shares of the company’s stock after purchasing an additional 2,481 shares during the period. Banque Cantonale Vaudoise’s holdings in HCA Healthcare were worth $4,953,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Terra Nova Asset Management LLC increased its position in HCA Healthcare by 0.3% during the third quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock worth $3,297,000 after acquiring an additional 26 shares during the period. Massmutual Trust Co. FSB ADV raised its position in shares of HCA Healthcare by 7.4% during the third quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock valued at $171,000 after buying an additional 29 shares during the last quarter. Waldron Private Wealth LLC grew its position in HCA Healthcare by 1.8% during the third quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock worth $683,000 after buying an additional 29 shares in the last quarter. Brookstone Capital Management lifted its position in shares of HCA Healthcare by 0.7% in the 3rd quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock worth $1,652,000 after acquiring an additional 30 shares during the period. Finally, UMB Bank n.a. increased its position in shares of HCA Healthcare by 2.4% during the third quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock valued at $529,000 after purchasing an additional 30 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Price Performance

HCA opened at $335.11 on Wednesday. HCA Healthcare, Inc. has a 52 week low of $245.03 and a 52 week high of $417.14. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The firm has a market capitalization of $84.88 billion, a PE ratio of 15.05, a P/E/G ratio of 1.32 and a beta of 1.68. The company has a fifty day moving average price of $383.10 and a two-hundred day moving average price of $358.30.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be paid a $0.66 dividend. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.79%. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.85%.

Wall Street Analyst Weigh In

HCA has been the topic of several analyst reports. Wells Fargo & Company boosted their price target on shares of HCA Healthcare from $395.00 to $400.00 and gave the company an “equal weight” rating in a report on Wednesday, November 6th. StockNews.com lowered shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Wolfe Research raised HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. Cantor Fitzgerald restated an “overweight” rating and issued a $392.00 target price on shares of HCA Healthcare in a research note on Tuesday, October 1st. Finally, Truist Financial boosted their price target on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research report on Monday, August 19th. Five analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $385.00.

Insider Buying and Selling

In other news, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the sale, the senior vice president now owns 52,702 shares of the company’s stock, valued at $18,445,700. This trade represents a 6.89 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. The trade was a 21.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 15,155 shares of company stock valued at $5,608,990 in the last 90 days. 1.70% of the stock is owned by insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.